Good price  online

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Breast Cancer Drugs
Created with Pixso. Palbociclib Capsules 75mg 21 Capsules Box CDK4 6 Inhibitor for HR Positive HER2 Negative Advanced Breast Cancer

Palbociclib Capsules 75mg 21 Capsules Box CDK4 6 Inhibitor for HR Positive HER2 Negative Advanced Breast Cancer

Brand Name: Sichuan Kelun Pharmaceutical Co., Ltd.
Model Number: Palbociclib KL-20223935
MOQ: Negotiable
Price: Please contact a specialist WhatsApp:55342706
Delivery Time: Negotiable
Payment Terms: Western Union,MoneyGram,T/T
Detail Information
Place of Origin:
Chengdu, Sichuan, China
Certification:
NMPA/GMP
Packaging Details:
Negotiable
Supply Ability:
Negotiable
Highlight:

CDK4 6 Selective Inhibitor

,

HR Positive Breast Cancer Therapy

,

First Line Metastatic Breast Cancer

Product Description

Palbociclib 75mg x 21 Capsules

[Product Name]

Generic Name: Palbociclib

Brand Name: Pailunxin

Specification: 75mg x 21 Capsules

[Active Ingredient]

Palbociclib

[Indications]

HR-positive, HER2-negative advanced/metastatic breast cancer with letrozole (first-line) or fulvestrant. 75mg is dose-reduction strength from 125mg.

[Mechanism of Action]

Highly selective CDK4/6 inhibitor. Prevents Rb phosphorylation, arresting G1-S cell cycle transition and inhibiting tumor proliferation.

[Dosage]

125mg starting dose daily 21 days on/7 off per 28-day cycle. Reduce to 100mg then 75mg for toxicity. Take with food.

[Adverse Reactions]

Neutropenia (75%), fatigue, nausea, stomatitis, alopecia, infections. Febrile neutropenia, pulmonary embolism, ILD.

[Storage]

Store below 30C. Keep out of reach of children.

[Shelf Life]

24 months

Approval: H20223935